ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5300.5031.2 (+0.59 %)
PREV CLOSE ( ) 5269.30
OPEN PRICE ( ) 5296.55
BID PRICE (QTY) 5300.45 (2)
OFFER PRICE (QTY) 5315.90 (1)
VOLUME 190
TODAY'S LOW / HIGH ( )5290.10 5371.65
52 WK LOW / HIGH ( )3118.55 7208
NSE5318.5533.75 (+0.64 %)
PREV CLOSE( ) 5284.80
OPEN PRICE ( ) 5321.75
BID PRICE (QTY) 5310.50 (1)
OFFER PRICE (QTY) 5318.55 (10)
VOLUME 2013
TODAY'S LOW / HIGH( ) 5288.10 5374.00
52 WK LOW / HIGH ( )3115.05 7220.95

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.